[Symptomatic tapetoretinal degeneration in pigment disorders of the skin: approaches to understanding the pathomechanism and therapy].
D000328:Adult; D001323:Autoantibodies / Q000032:analysis; D001327:Autoimmune Diseases / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008544:Melanocytes / Q000276:immunology; D012174:Retinitis Pigmentosa / Q000188:drug therapy / Q000276:immunology*; D014820:Vitiligo / Q000188:drug therapy / Q000276:immunology*
D001323:Autoantibodies; D007166:Immunosuppressive Agents
Symptomatische tapetoretinale Degeneration bei Pigmentstörungen der Haut: Ansätze zum Verständnis des Schadensmechanismus und zur Therapie.